On July 10, Definium Therapeutics fell 5.06% in regular trading, trading at $45.96 USD/share, with Turnover of $9.66 million.
Within the Pharmacy sector where Definium Therapeutics belongs, the overall sector showed mixed performance. Among individual stocks, Eli Lilly down 1.66%, Johnson & Johnson up 0.17%, AstraZeneca down 2.78%, Crinetics Pharmaceuticals up 0.07%, Pfizer up 0.37%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)